Patent · US Active

Neutralizing anti-influenza binding molecules and uses thereof

US10882897B2 · kind B2 · utility

2Cited by

18References

14Claims

0Family size

Assignee

MedImmune Limited · US

Inventors

Nicole Kallewaard-Lelay · Gaithersburg, US
Qing Zhu · Mansfield Center, US
Godfrey Jonah Anderson Rainey · Gaithersburg, US
Cuihua Gao · Gaithersburg, US
Srinath Kasturirangan · Gaithersburg, US
Changshou Gao · Potomac, US

Key dates

Filing date	Sep 4, 2019
Grant date	Jan 5, 2021
Priority date	—
Expiry date	Sep 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Binding molecules, including bispecific antibodies that include at least two anti-influenza binding domains are disclosed, including binding molecules having a first binding domain that specifically binds influenza A virus and a second binding domain that specifically binds influenza B virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.